Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Exploring the role of endogenous TDP-43 SUMOylation in mice: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
FY 2021-22
Summary
Thousands of Canadians die annually from Amyotrophic lateral sclerosis (ALS): a progressive neurodegenerative disease characterized by death of motor neurons. Patients suffer impaired motor function and typically die within 2-5 years of diagnosis to respiratory insufficiency. Additionally, ALS exists on a disease continuum with Frontotemporal Dementia (FTD) where the loss of brain neurons manifests in altered behaviour, cognition and, emotional and social processing. Common to both diseases, the protein TDP-43 is mislocalized and aggregated in cells in nearly all ALS and many FTD patients despite mutations in its gene found in only a small subset. TDP-43 is critical for various cellular activities and one mechanism of regulation is SUMOylation where small proteins are attached. Little is known about what role SUMOylation plays in TDP-43 misregulation in the context of disease and currently no models exist to advance this area. This project will characterize a novel mouse model of ALS-FTD in which TDP-43 is mutated such that SUMOylation is blocked. The behavioural and histological consequences will be investigated for features that recapitulate ALS-FTD disease state. Behavioural assays will test for motor impairment, exploration, cognitive, executive skills, and general wellbeing. Histologically, markers for TDP-43 pathology, death and inflammation in the nervous system, and loss of muscle innervation will be examined. The expected findings from this project are that blocking the SUMOylation of TDP-43 will produce changes in the model characteristic of ALS-FTD patients. Uncovering the role of TDP-43 SUMOylation will provide important insights into disease pathogenesis and guide discovery of TDP-43 related biomarkers and development of novel therapeutic interventions.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
480737
Name
Part Caroline E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of endogenous TDP-43 SUMOylation in mice: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Amyotrophic Lateral Sclerosis; Behaviour; Frontotemporal Dementia; Mislocalization; Mouse Model; Neurodegeneration; Preclinical; Sumoylation; Tdp-43
Abstract
Thousands of Canadians die annually from Amyotrophic lateral sclerosis (ALS): a progressive neurodegenerative disease characterized by death of motor neurons. Patients suffer impaired motor function and typically die within 2-5 years of diagnosis to respiratory insufficiency. Additionally, ALS exists on a disease continuum with Frontotemporal Dementia (FTD) where the loss of brain neurons manifests in altered behaviour, cognition and, emotional and social processing. Common to both diseases, the protein TDP-43 is mislocalized and aggregated in cells in nearly all ALS and many FTD patients despite mutations in its gene found in only a small subset. TDP-43 is critical for various cellular activities and one mechanism of regulation is SUMOylation where small proteins are attached. Little is known about what role SUMOylation plays in TDP-43 misregulation in the context of disease and currently no models exist to advance this area. This project will characterize a novel mouse model of ALS-FTD in which TDP-43 is mutated such that SUMOylation is blocked. The behavioural and histological consequences will be investigated for features that recapitulate ALS-FTD disease state. Behavioural assays will test for motor impairment, exploration, cognitive, executive skills, and general wellbeing. Histologically, markers for TDP-43 pathology, death and inflammation in the nervous system, and loss of muscle innervation will be examined. The expected findings from this project are that blocking the SUMOylation of TDP-43 will produce changes in the model characteristic of ALS-FTD patients. Uncovering the role of TDP-43 SUMOylation will provide important insights into disease pathogenesis and guide discovery of TDP-43 related biomarkers and development of novel therapeutic interventions.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Part, Caroline E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~